Diabetes and Endocrinology

MinuteCE®
Endocrinologists and PCPs: The Frontline Defense Against Cirrhosis in Patients with Type 2 Diabetes
- Jeff McIntyre
  Peer
- Naim Alkhouri, MD, FAASLD, DABOM
  Peer
- Robert H. Eckel, MD, FAHA, FACC, FNLA
  Peer
- Tessa Janovsky, PA-C
  Peer
1.00 credits 9 episodes
Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results
MinuteCE®
Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results
- Christie M. Ballantyne, MD, FACP, FACC
  Peer
0.75 program credits
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
CME/CE
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
- Scott Kahan, MD, MPH
  Peer
- Ken Fujioka, MD
  Peer
- Carol Wysham, MD
  Peer
0.50 credits
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Heart Matters
Main Messages of New ESC Guidelines for CVD Management in Diabetes